GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Imexpharm Corp (STC:IMP) » Definitions » Additional Paid-In Capital

Imexpharm (STC:IMP) Additional Paid-In Capital : ₫507,368 Mil(As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Imexpharm Additional Paid-In Capital?


Imexpharm's quarterly additional paid-in capital stayed the same from Sep. 2023 (₫507,368 Mil) to Dec. 2023 (₫507,368 Mil) and stayed the same from Dec. 2023 (₫507,368 Mil) to Mar. 2024 (₫507,368 Mil).

Imexpharm's annual additional paid-in capital stayed the same from Dec. 2021 (₫507,368 Mil) to Dec. 2022 (₫507,368 Mil) and stayed the same from Dec. 2022 (₫507,368 Mil) to Dec. 2023 (₫507,368 Mil).

Imexpharm Additional Paid-In Capital Historical Data

The historical data trend for Imexpharm's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imexpharm Additional Paid-In Capital Chart

Imexpharm Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 601,241.08 507,368.25 507,368.25 507,368.25 507,368.25

Imexpharm Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 507,368.25 507,368.25 507,368.25 507,368.25 507,368.25

Imexpharm Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Imexpharm Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Imexpharm's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Imexpharm (STC:IMP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Imexpharm Corp (STC:IMP) » Definitions » Additional Paid-In Capital
Comparable Companies
STC:TRA STC:DMC STC:DHG ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB BOM:500124 VTRS NBIX SZSE:000963 SHSE:600085 XPAR:IPN
Traded in Other Exchanges
N/A
Address
4 Road 30/04 Street Ward 1, Cao Lanh City, Dongthap, VNM
Website
http://www.imexpharm.com
Imexpharm Corp is engaged in the manufacture, import, export, and trade of pharmaceuticals and medicinal chemical products. Its products include oral and injective antibiotic, digestion, central nervous system, cardiovascular, diabetes, musculoskeletal system, respiratory system, analgesic-anti-inflammatory, anti-allergy, ophthalmology, external drugs, and anti-parasitic, as well as vitamins and minerals.

Imexpharm (STC:IMP) Headlines

No Headlines